logo

Tenax Therapeutics Inc (TENX)



Trade TENX now with
  Date
  Headline
7/6/2020 9:03:11 PM Tenax Therapeutics Announces $8.0 Mln Registered Direct And PIPE Offerings
6/3/2020 8:32:18 AM Tenax Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
6/2/2020 7:35:37 AM Tenax Therapeutics Reports Positive Results From Phase 2 Trial Of Levosimendan In Patients With PH-HFpEF
4/9/2020 8:35:29 AM Tenax Therapeutics Announces Last Patient Completes Final Visit In Phase 2 HELP Study Of Levosimendan For PH-HFpEF
3/12/2020 8:33:05 AM Tenax Therapeutics Completes Enrollment In Phase 2 Pulmonary Hypertension Trial
3/12/2020 8:10:30 AM Tenax Therapeutics Announces $2.75 Mln Registered Direct Offering Priced At-the-Market
1/13/2020 8:40:37 AM Tenax Updates On Phase 2 Pulmonary Hypertension Clinical Trial; Expects Full Enrollment In Q1
10/31/2019 8:27:39 AM Tenax Therapeutics Provides Update On On-going Clinical Trial Of Levosimendan
3/11/2019 8:33:40 AM Tenax Enrolls First Patient For Phase 2 Pulmonary Hypertension Clinical Trial
12/11/2018 4:05:32 PM Tenax Therapeutics Closes $10 Mln Underwritten Offering
8/28/2018 8:36:02 AM Tenax Therapeutics: Clinical Study Results Say Levosimendan Offers Renal Protective Benefits To Heart Failure Patients
6/5/2018 4:36:56 PM Tenax Therapeutics Appoints Anthony DiTonno As CEO
6/1/2018 8:37:54 AM Tenax Therapeutics Reports Study Design For Phase 2 Trial Of Levosimendan In PH-HFpEF Patients